CN111374934A - 脂质体包裹人干细胞因子的制备及皮肤损伤修复检测方法 - Google Patents
脂质体包裹人干细胞因子的制备及皮肤损伤修复检测方法 Download PDFInfo
- Publication number
- CN111374934A CN111374934A CN202010193738.XA CN202010193738A CN111374934A CN 111374934 A CN111374934 A CN 111374934A CN 202010193738 A CN202010193738 A CN 202010193738A CN 111374934 A CN111374934 A CN 111374934A
- Authority
- CN
- China
- Prior art keywords
- liposome
- stem cell
- suspension
- culture
- mesenchymal stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101000716729 Homo sapiens Kit ligand Proteins 0.000 title claims abstract description 16
- 102000055151 human KITLG Human genes 0.000 title claims abstract description 16
- 238000001514 detection method Methods 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 230000008439 repair process Effects 0.000 title claims abstract description 9
- 208000028990 Skin injury Diseases 0.000 title abstract description 6
- 239000002502 liposome Substances 0.000 claims abstract description 95
- 239000000725 suspension Substances 0.000 claims abstract description 68
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims abstract description 47
- 238000004113 cell culture Methods 0.000 claims abstract description 29
- 210000000130 stem cell Anatomy 0.000 claims abstract description 19
- 239000012228 culture supernatant Substances 0.000 claims abstract description 10
- 238000003860 storage Methods 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 58
- 238000000034 method Methods 0.000 claims description 31
- 238000012360 testing method Methods 0.000 claims description 29
- 239000001963 growth medium Substances 0.000 claims description 26
- 230000000694 effects Effects 0.000 claims description 25
- 239000000243 solution Substances 0.000 claims description 17
- 238000012258 culturing Methods 0.000 claims description 15
- 238000005538 encapsulation Methods 0.000 claims description 15
- 102000004169 proteins and genes Human genes 0.000 claims description 15
- 108090000623 proteins and genes Proteins 0.000 claims description 15
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 14
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 14
- 229960002591 hydroxyproline Drugs 0.000 claims description 14
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 14
- 239000008055 phosphate buffer solution Substances 0.000 claims description 13
- 239000002245 particle Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 10
- 230000012010 growth Effects 0.000 claims description 9
- 230000001678 irradiating effect Effects 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 8
- 238000009210 therapy by ultrasound Methods 0.000 claims description 8
- 238000010609 cell counting kit-8 assay Methods 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 238000000108 ultra-filtration Methods 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 claims description 6
- 108010087230 Sincalide Proteins 0.000 claims description 6
- 238000002835 absorbance Methods 0.000 claims description 6
- 239000006285 cell suspension Substances 0.000 claims description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 claims description 6
- 239000004017 serum-free culture medium Substances 0.000 claims description 6
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 claims description 6
- 239000000427 antigen Substances 0.000 claims description 5
- 102000036639 antigens Human genes 0.000 claims description 5
- 108091007433 antigens Proteins 0.000 claims description 5
- 235000012000 cholesterol Nutrition 0.000 claims description 5
- 230000002062 proliferating effect Effects 0.000 claims description 5
- 230000035755 proliferation Effects 0.000 claims description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 4
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 claims description 4
- 239000006143 cell culture medium Substances 0.000 claims description 4
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 claims description 4
- 238000005138 cryopreservation Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000002609 medium Substances 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 4
- 150000008104 phosphatidylethanolamines Chemical class 0.000 claims description 4
- 210000001626 skin fibroblast Anatomy 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 229940042585 tocopherol acetate Drugs 0.000 claims description 4
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 4
- 230000007910 cell fusion Effects 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000000887 hydrating effect Effects 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000001502 supplementing effect Effects 0.000 claims description 3
- 238000010257 thawing Methods 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 claims description 2
- 238000007710 freezing Methods 0.000 claims description 2
- 230000008014 freezing Effects 0.000 claims description 2
- 230000037380 skin damage Effects 0.000 claims description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000002525 ultrasonication Methods 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 31
- 102000008186 Collagen Human genes 0.000 description 15
- 108010035532 Collagen Proteins 0.000 description 15
- 229920001436 collagen Polymers 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 11
- 239000013543 active substance Substances 0.000 description 10
- 210000003954 umbilical cord Anatomy 0.000 description 9
- 230000032683 aging Effects 0.000 description 7
- 210000004207 dermis Anatomy 0.000 description 7
- 210000002615 epidermis Anatomy 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 239000012091 fetal bovine serum Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000012466 permeate Substances 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 102000004127 Cytokines Human genes 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 239000003102 growth factor Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- 102100032912 CD44 antigen Human genes 0.000 description 3
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 3
- 206010051246 Photodermatosis Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 238000013270 controlled release Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 210000002969 egg yolk Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000005260 human cell Anatomy 0.000 description 3
- 206010020718 hyperplasia Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000008845 photoaging Effects 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 102100022464 5'-nucleotidase Human genes 0.000 description 2
- 102100037241 Endoglin Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 2
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 2
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 2
- 101000881679 Homo sapiens Endoglin Proteins 0.000 description 2
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000002390 hyperplastic effect Effects 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- SRLOHQKOADWDBV-NRONOFSHSA-M sodium;[(2r)-2,3-di(octadecanoyloxy)propyl] 2-(2-methoxyethoxycarbonylamino)ethyl phosphate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCCNC(=O)OCCOC)OC(=O)CCCCCCCCCCCCCCCCC SRLOHQKOADWDBV-NRONOFSHSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- -1 hydroxyl free radical Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 125000001095 phosphatidyl group Chemical group 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/982—Reproductive organs; Embryos, Eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Reproductive Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010193738.XA CN111374934A (zh) | 2020-03-19 | 2020-03-19 | 脂质体包裹人干细胞因子的制备及皮肤损伤修复检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010193738.XA CN111374934A (zh) | 2020-03-19 | 2020-03-19 | 脂质体包裹人干细胞因子的制备及皮肤损伤修复检测方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111374934A true CN111374934A (zh) | 2020-07-07 |
Family
ID=71213693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010193738.XA Pending CN111374934A (zh) | 2020-03-19 | 2020-03-19 | 脂质体包裹人干细胞因子的制备及皮肤损伤修复检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111374934A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112546072A (zh) * | 2020-12-24 | 2021-03-26 | 苏州倍乐勇生物科技有限公司 | 一种脂质体包裹人干细胞混悬液的制备方法 |
WO2023012722A1 (en) * | 2021-08-06 | 2023-02-09 | Leadermed Champion Limited | miRNA-BASED COMPOSITIONS AND METHODS OF USE THEREOF |
CN113813289B (zh) * | 2021-09-07 | 2023-10-27 | 深圳市莱利赛生物科技有限公司 | 基于脐带间充质干细胞外泌体的毛囊生成促进液制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106176563A (zh) * | 2016-07-26 | 2016-12-07 | 西安艾尔菲生物科技有限公司 | 人脐带msc无血清培养液脂质体冻干粉及其制备和应用 |
CN108904534A (zh) * | 2018-08-02 | 2018-11-30 | 傅松涛 | 一种干细胞分泌因子柔性脂质体的制备方法 |
-
2020
- 2020-03-19 CN CN202010193738.XA patent/CN111374934A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106176563A (zh) * | 2016-07-26 | 2016-12-07 | 西安艾尔菲生物科技有限公司 | 人脐带msc无血清培养液脂质体冻干粉及其制备和应用 |
CN108904534A (zh) * | 2018-08-02 | 2018-11-30 | 傅松涛 | 一种干细胞分泌因子柔性脂质体的制备方法 |
Non-Patent Citations (1)
Title |
---|
刘美林等: "人脐带间充质干细胞条件培养基脂质体修复大鼠皮肤创面损伤", 《中国组织工程研究》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112546072A (zh) * | 2020-12-24 | 2021-03-26 | 苏州倍乐勇生物科技有限公司 | 一种脂质体包裹人干细胞混悬液的制备方法 |
WO2023012722A1 (en) * | 2021-08-06 | 2023-02-09 | Leadermed Champion Limited | miRNA-BASED COMPOSITIONS AND METHODS OF USE THEREOF |
CN113813289B (zh) * | 2021-09-07 | 2023-10-27 | 深圳市莱利赛生物科技有限公司 | 基于脐带间充质干细胞外泌体的毛囊生成促进液制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111374934A (zh) | 脂质体包裹人干细胞因子的制备及皮肤损伤修复检测方法 | |
AU2018201536B2 (en) | Skin Substitutes And Methods For Hair Follicle Neogenesis | |
JP5981947B2 (ja) | スキンクリーム | |
EP2582791B1 (en) | Hair follicle neogenesis | |
JP2013224323A (ja) | スキンケア組成物及び治療法 | |
CN105534848B (zh) | 一种化妆品或药物组合物及其用途 | |
CN110548002A (zh) | 一种用于抗皮肤衰老的人源干细胞外泌体组合物 | |
CN110184235B (zh) | 一种adsc外泌体及其制备方法与应用 | |
CN108904534A (zh) | 一种干细胞分泌因子柔性脂质体的制备方法 | |
CN105820998A (zh) | 临床回输级细胞治疗用人脂肪干细胞ADSCs分离提取培养方法 | |
CN111690600A (zh) | 一种工程化人脐带间充质干细胞外泌体及透皮制剂与应用 | |
CN108265023A (zh) | 一种增殖促进剂及其应用 | |
WO2021077812A1 (zh) | 脐带间充质干细胞因子冻干粉、制备方法及其应用 | |
US20220287952A1 (en) | Compositions containing exosomes from animal placenta, methods for producing the same and uses thereof | |
CN114515353A (zh) | 一种基于脐带干细胞和脐带干细胞外泌体的复合水凝胶、其制备方法及应用 | |
CN111821250A (zh) | 抗衰老组合物及其制备方法与应用 | |
Tian et al. | Co-delivery of bioactive peptides by nanoliposomes for promotion of hair growth | |
CN116410918B (zh) | 一种皮肤类器官外泌体及其制备方法和应用 | |
CN113171332A (zh) | 一种外泌体冻干粉、其制备方法及护肤品 | |
CN106265518B (zh) | Fgf脂质体及其制备方法 | |
CN109182264A (zh) | 制备人脂肪干细胞培养液的方法及其在美容用品中的应用 | |
CN111888379A (zh) | 干细胞来源的微囊泡在制备修复瘢痕的制剂中的应用 | |
CN112245451A (zh) | 脐带间质干细胞来源的微囊泡在制备促创伤后皮肤附属结构再生的制剂中的应用 | |
Rizal et al. | The increase of VEGF expressions and new blood vessels formation in Wistar rats induced with post-tooth extraction sponge amnion | |
CN111297905B (zh) | 一种基于皮肤前体细胞的提取物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210901 Address after: 215000 Room 102, building 3, Taihu new town science and Innovation Park, No. 18, Suzhou River Road, East Taihu Lake ecotourism Resort (Taihu new town), Wujiang District, Suzhou City, Jiangsu Province Applicant after: Suzhou Wujiang Houpu Biomedical Technology Co.,Ltd. Address before: Room 201-206, building A5, bio nano Park, 218 Xinghu street, industrial park, Suzhou, Jiangsu 215000 Applicant before: HOPE BIOLOGICAL TECHNOLOGY (SUZHOU) Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200707 |
|
RJ01 | Rejection of invention patent application after publication |